The Trump administration convinced a federal judge to put on hold a lawsuit over the abortion medication mifepristone, giving the FDA time to conduct a long-awaited safety review of the drug.
Tuesday’s order pauses litigation brought by Louisiana seeking to restrict access to mifepristone. Louisiana filed the lawsuit in October against the Food and Drug Administration, claiming an agency decision under former President Joe Biden allowed the drug to be mailed into the state, making it difficult to enforce their abortion restrictions.
Under the Trump administration, the FDA has said it would review the safety of mifepristone. The agency has ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.